Home › Scleroderma › Massachusetts › Boston
Scleroderma clinical trials in Boston, MA
7 studies for Scleroderma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RecruitingPhase 3
- Massachusetts General Hospital, Boston
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- Boston Medical Center, Boston
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Massachusetts General Hospital, Boston
- Boston University (BU), Boston
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
RecruitingHealthy volunteers welcome
- Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
- Brigham And Womens Hospital, Boston
Open Label Treprostinil Raynaud's Study
RecruitingPhase 4
- Brigham and Women's Hospital, Boston
- Brigham and Women's Hospital, Boston
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Chicago, IL10 studies
- Houston, TX9 studies
- Los Angeles, CA7 studies
- Durham, NC7 studies
- Philadelphia, PA6 studies
- Baltimore, MD6 studies
- New Orleans, LA6 studies
- Pittsburgh, PA5 studies
- Dallas, TX5 studies
- Charleston, SC4 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer61 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.